Literature DB >> 2789113

Reversible interleukin-2 response defects in systemic lupus erythematosus.

R J Warrington1, P J Sauder, J Homik, W Ofosu-Appiah.   

Abstract

Limiting dilution analysis techniques were used to determine precursor frequencies for interleukin-2 (IL-2) responsive cells among the peripheral blood lymphocytes of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis compared with healthy subjects. Response defects in SLE were found, but were of two types: reduced precursor frequencies with normal pattern of response (single-hit kinetics); and abnormal multi-hit responsiveness. These abnormalities were not more frequent statistically in those with active disease. Precursor frequencies of SLE peripheral blood lymphocytes were enhanced by resting the cells for up to 72 h prior to activation, and by adding exogenous IL-2 during the initial activation step. The IL-2 response defects of SLE are therefore reversible and may in part be secondary to other in vivo abnormalities, such as deficient IL-2 production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789113      PMCID: PMC1541987     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosus.

Authors:  M S Gawryl; D S Chudwin; P F Langlois; T F Lint
Journal:  Arthritis Rheum       Date:  1988-02

2.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

3.  Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. A role for overproduction of interleukin-2 in human autoimmunity?

Authors:  R J Warrington
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  In vitro correction of the interleukin 2 defect of autoimmune mice.

Authors:  T J Santoro; T A Luger; E S Ravache; J S Smolen; J J Oppenheim; A D Steinberg
Journal:  Eur J Immunol       Date:  1983-07       Impact factor: 5.532

6.  Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.

Authors:  M Linker-Israeli; A C Bakke; F P Quismorio; D A Horwitz
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Characterization of synovial T lymphocytes in rheumatoid arthritis. I. Production of IL-2 dependent T cell clones from synovial fluid and peripheral blood.

Authors:  W A Ofosu-Appiah; R M McKenna; R J Warrington; J A Wilkins
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

8.  Hypothesis: the role of interleukins in lymphopoiesis - important in autoimmune disease?

Authors:  H M Dosch; A Shore
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

9.  Induction and upregulation by interleukin 2 of high-affinity interleukin 2 receptors on thymocytes and T cells.

Authors:  G H Reem; N H Yeh; D L Urdal; P L Kilian; J J Farrar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.

Authors:  Y P Huang; P A Miescher; R H Zubler
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

View more
  1 in total

Review 1.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.